RxDoctor Payments Data

Anthony Gregory, NP

Family · Dawson, GANPI 1811537574

Payments from drug & device makers

$1,664in general payments, 2019–2025

Across 87 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$475
  • Lilly USA, LLC$177
  • GSK$161
  • Pfizer$151
  • Biohaven Pharmaceutical Holding Company Ltd.$95
  • Boehringer Ingelheim$89
  • plus $516 from 14 others

What the payments were for

  • Food & beverage$1,664100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,664 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$24,434
Medicare patients
141
Services billed
490

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron13$9,862
GemtesaVibegron11$6,126
Oxybutynin Chloride ErOxybutynin Chloride127$3,303
Tamsulosin Hcl268$2,624
Desmopressin Acetate20$1,389
Testosterone Cypionate20$676
Finasteride60$421
Ciprofloxacin Hcl50$349
Alfuzosin Hcl ErAlfuzosin Hcl19$196
Dutasteride12$159
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim28$98

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$61$9,86213 claims
Sumitomo Pharma America, Inc.Gemtesa$18$6,12611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.

Other family in Dawson

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →